| 期刊全稱(chēng) | Antitumor Antibiotics | | 影響因子2023 | S. K. Carter (Director),Hamao Umezawa (Head),Yoshi | | 視頻video | http://file.papertrans.cn/159/158696/158696.mp4 | | 學(xué)科分類(lèi) | Recent Results in Cancer Research | | 圖書(shū)封面 |  | | 影響因子 | The scientific collaboration between the United States and Japan in the field of cancer goes back many years. In this successful international collaboration cancer chemotherapy has been one of the most productive areas. Pioneers such as YOSHIDA, UMEZAWA, SHEAR, and GOLDIN established firm links of mutual trust and respect in the period after the Second Great War. Japanese drugs, such as mitomycin C and bleomycin have become mainstays of clinical oncology in the U. S. and throughout the world. Many drugs developed in the U. S. have become established in Japanese cancer therapy. Within the cancer chemotherapy field the antitumor antibiotics rank as one of the most important groups. In the U . S. -J apanese collaboration this group of drugs has taken the paramount role. The Japanese, under the leadership of U mezawa, are considered to be among the most innovative and productive in this area which has also had great emphasis in the United States as part of the National Cancer Institute‘s drug development program and in the pharmaceutical industry. This extended collaboration in general oncology, and chemotherapy in particular, has received increased impetus by and support from the offi | | Pindex | Book 1978 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-29 07:10
發(fā)表于 2025-3-21 16:04:13
